![](/img/cover-not-exists.png)
Final analysis of the ECOG I-COPA trial (E6484) in patients with non-Hodgkin’s lymphoma treated with interferon alfa (IFN-α2a) plus an anthracycline-based induction regimen
Smalley, R V, Weller, E, Hawkins, M J, Oken, M M, O’Connell, M J, Haase-Statz, S, Borden, E CVolume:
15
Year:
2001
Language:
english
Pages:
5
DOI:
10.1038/sj.leu.2402161
File:
PDF, 112 KB
english, 2001